MPCI logo

Memphis Pharmaceuticals & Chemical Industries Stock Price

CASE:MPCI Community·ج.م3.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

MPCI Share Price Performance

ج.م172.99
115.09 (198.77%)
ج.م172.99
115.09 (198.77%)
Price ج.م172.99

MPCI Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Outstanding track record with flawless balance sheet.

4 Risks
2 Rewards

Memphis Pharmaceuticals & Chemical Industries Key Details

ج.م1.6b

Revenue

ج.م909.9m

Cost of Revenue

ج.م696.1m

Gross Profit

ج.م178.7m

Other Expenses

ج.م517.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
22.74
43.34%
32.22%
15.0%
View Full Analysis

About MPCI

Founded
1940
Employees
n/a
CEO
Mohamed Ibrahim
WebsiteView website
www.memphis.com.eg

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms. The company was founded in 1940 and is based in Cairo, Egypt. Memphis Pharmaceuticals & Chemical Industries is a subsidiary of HoldiPharma.

Recent MPCI News & Updates

Recent updates

No updates

Memphis Pharmaceuticals & Chemical Industries Competitors